1-4 of 4
Rushang D. Patel, MD, PhD
Close
Sort by
Journal Articles

Clinical Utility of Multiple-Gene Mutation Testing By Next-Generation Sequencing in Acute Myeloid Leukemia in Community Hospital Setting

Jingxin Sun, MD PhD, Luwei Tao, MD PhD, Rushang D. Patel, MD PhD, Shahram Mori, MD PhD, Jeff Chang, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4004.
https://doi.org/10.1182/blood-2018-99-119427
Published: 2018
Journal Articles

Addition of Cladribine: Improving Standard of Care in Newly Diagnosed Acute Myeloid Leukemia

Shahram Mori, MD PhD, Nahir Rivera, PharmD BCOP, Mohammed Wazir, MD, Rushang D. Patel, MD PhD, Juan Carlos Varela, MD PhD, Xiang Zhu, MAS, Jason Balls, PAC, Tori Smith, ARNP, Steven C. Goldstein, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3988.
https://doi.org/10.1182/blood-2018-99-120285
Published: 2018
Journal Articles

Acute Promyelocytic Leukemia with FLT3/ITD and RUNX1 Mutation Presenting As Extramedullary Soft Tissue Mass

Shahram Mori, MD PhD, Cai Yuan, MD, Wesam B. Ahmed, MD PhD, Rushang D. Patel, MD PhD
Journal: Blood
Blood (2016) 128 (22): 5185.
https://doi.org/10.1182/blood.V128.22.5185.5185
Published: 2016
Journal Articles

A Retrospective Analysis Of The Association Between Common Myeloablative Conditioning Regimens and Hepatotoxicity

Rushang D. Patel, MD, PhD, Thomas R. Klumpp, MD, Mary Ellen Martin, MD, Patricia Kropf, MD, Omotayo O. Fasan, MBBS, Kenneth F. Mangan, MD
Journal: Blood
Blood (2013) 122 (21): 5515.
https://doi.org/10.1182/blood.V122.21.5515.5515
Published: 2013